The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clindamycin     Quarter: 2016Q3

Total Records: 475     Number of Pages: 24

DRUGNAME PT EventCount
CLINDAMYCIN Tongue coated 3
CLINDAMYCIN Treatment failure 3
CLINDAMYCIN Weight increased 3
CLINDAMYCIN HCL Anaphylactic reaction 3
CLINDAMYCIN HCL Erythema 3
CLINDAMYCIN HYDROCHLORIDE. Rash maculo-papular 3
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Drug effect decreased 3
CLINDAMYCIN Abdominal discomfort 2
CLINDAMYCIN Abdominal pain upper 2
CLINDAMYCIN Acute generalised exanthematous pustulosis 2
CLINDAMYCIN Blindness cortical 2
CLINDAMYCIN Blood pressure decreased 2
CLINDAMYCIN Blood pressure increased 2
CLINDAMYCIN Colitis 2
CLINDAMYCIN Condition aggravated 2
CLINDAMYCIN Dizziness 2
CLINDAMYCIN Drug intolerance 2
CLINDAMYCIN Enterobacter infection 2
CLINDAMYCIN Eructation 2
CLINDAMYCIN Faeces discoloured 2

Total Records: 475     Number of Pages: 24